By contrast, IDH‐NO tumors exhibit increased exhausted marker expression and greater T cell infiltration in ICC, and those tumors are considered to be more immunologically hot and more susceptible to immunotherapies. Here, IDH2 is linked to intrahepatic cholangiocarcinoma.